FDA Media Briefing: Janssen COVID-19 Vaccine
For Immediate Release: Tuesday, April 13, 2021
Contact: Media Relations
A joint media briefing with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss six reported cases of a rare type of blood clot in individuals who received the Janssen COVID-19 Vaccine.
This media briefing will be live streamed over the FDA’s YouTube page.
- Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research
- Anne Schuchat, M.D., principal deputy director, CDC
Tues., Apr. 13 at 10:00 a.m. ET
Callers in the United States or Canada may call 800-857-9789. International callers will need to dial 1-517-308-9484. The passcode for all participants is 7809201.
Following the media briefing, a replay will be available on the FDA’s YouTube page.
For other questions about the media briefing, please contact the FDA’s Office of Media Affairs at firstname.lastname@example.org.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
CDC works 24/7 protecting America’s health, safety and security. Whether disease start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.